Article
[Perampanel in the treatment of a patient with glioblastoma multiforme without IDH1 mutation and without MGMT promotor methylation].
Fortschritte der Neurologie-Psychiatrie - 1 May 2015
Rösche J, Piek J, Hildebrandt G, Grossmann A, Kirschstein T, Benecke R
Abstract excerpt
Malignant gliomas like glioblastoma multiforme (GBM) release glutamate which causes excitotoxic death to surrounding neurons, thereby vacating room for tumor expansion. We report the case of a patient with GBM treated with the AMPA receptor blocker Perampanel (PER) in combination therapy for partial seizures. Histological work-up of a biopsy showed the tissue of a GBM without mutation of the isocitrate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
